Anticorps Monoclonal anti-Angiotensinogen/AGT

Angiotensinogen/AGT Monoclonal Antibody for WB, IHC, IF/ICC, Indirect ELISA

Hôte / Isotype

Mouse / IgG2b

Réactivité testée

Humain, porc

Applications

WB, IHC, IF/ICC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1B2F5

N° de cat : 68020-1-PBS

Synonymes

AGT, Angiotensinogen, Serpin A8, SERPINA8, 1B2F5



Informations sur le produit

68020-1-PBS cible Angiotensinogen/AGT dans les applications de WB, IHC, IF/ICC, Indirect ELISA et montre une réactivité avec des échantillons Humain, porc

Réactivité Humain, porc
Hôte / Isotype Mouse / IgG2b
Clonalité Monoclonal
Type Anticorps
Immunogène Angiotensinogen/AGT Protéine recombinante Ag16658
Nom complet angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
Masse moléculaire calculée 485 aa, 53 kDa
Poids moléculaire observé52 kDa
Numéro d’acquisition GenBankBC011519
Symbole du gène AGT
Identification du gène (NCBI) 183
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Angiotensinogen is a precursor of angiotensin II (Ang II), is expressed and synthesized largely in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. It has a key role in mediating vascular constriction and regulating salt and fluid homeostasis. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene also have been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.

{{ptg:RelatedPrimaryAntibodies}}